ConductScience.org, home

Paper39484162

Cancer metabolic reprogramming and precision medicine-current perspective.

Gao T and 4 others. Front Pharmacol, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Cancer metabolic reprogramming and precision medicine-current perspective. Papers, record 39484162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39484162

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer metabolic reprogramming and precision medicine-current perspective.
PubMed
Journal
Front Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.64, provisional
iCite
Revised in PubMed
2024-11-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gao TTingting
2Yang LLiuxin
3Zhang YYali
4Bajinka OOusman
5Yuan XXingxing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138430694Cancer energy reprogramming and the immune responses.Cytokine2024https://conductscience.org/library/papers/38430694PubMed
237203277Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)-Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37203277PubMed
338486026Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma.Sci Rep2024https://conductscience.org/library/papers/38486026PubMed
438540735The Role of MUC1 in Renal Cell Carcinoma.Biomolecules2024https://conductscience.org/library/papers/38540735PubMed
536793241SLC3A2 promotes tumor-associated macrophage polarization through metabolic reprogramming in lung cancer.Cancer Sci2023https://conductscience.org/library/papers/36793241PubMed
636860371
Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/36860371PubMed
738627967Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition.Mol Ther2024https://conductscience.org/library/papers/38627967PubMed
838200551Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis.Mol Cancer2024https://conductscience.org/library/papers/38200551PubMed
938218970USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.Cell Death Dis2024https://conductscience.org/library/papers/38218970PubMed
1037370109Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37370109PubMed
1137441073Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming.Front Immunol2023https://conductscience.org/library/papers/37441073PubMed
1237064872The role of lipid metabolic reprogramming in tumor microenvironment.Theranostics2023https://conductscience.org/library/papers/37064872PubMed
1337226933The inhibition of Aurora A kinase regulates phospholipid remodeling by upregulating LPCAT1 in glioblastoma.Neoplasma2023https://conductscience.org/library/papers/37226933PubMed
1437664033Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer.Front Oncol2023https://conductscience.org/library/papers/37664033PubMed
1538317509PHGDH knockdown increases sensitivity to SR1, an aryl hydrocarbon receptor antagonist, in colorectal cancer by activating the autophagy pathway.FEBS J2024https://conductscience.org/library/papers/38317509PubMed
1638420794Metabolic Landscape of Osteosarcoma: Reprogramming of Lactic Acid Metabolism and Metabolic Communication.Front Biosci (Landmark Ed)2024https://conductscience.org/library/papers/38420794PubMed
1737161350The role of noncoding RNAs in metabolic reprogramming of cancer cells.Cell Mol Biol Lett2023https://conductscience.org/library/papers/37161350PubMed
1838171333Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer.Cell Metab2024https://conductscience.org/library/papers/38171333PubMed
1937012319Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.Br J Cancer2023https://conductscience.org/library/papers/37012319PubMed
2038040418Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma.J Immunother Cancer2023https://conductscience.org/library/papers/38040418PubMed

See all 69 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42733429Metabolic reprogramming-mediated therapeutic resistance in renal cell carcinoma: Mechanisms and targeted intervention strategies.iScience2026https://conductscience.org/library/papers/42733429PubMed
42639042Context-dependent roles of UCP2 in cancer: functional heterogeneity, molecular mechanisms and translational perspectives.Front Oncol2026https://conductscience.org/library/papers/42639042PubMed
42144529Clinical Trials and Translational Advances in Metabolic Targeting.Cancer Treat Res2026https://conductscience.org/library/papers/42144529PubMed
42082463Multi-omics reveals CXCR4 drives immune escape in colorectal cancer via metabolic reprogramming and immune microenvironment remodeling.Cell Death Dis2026https://conductscience.org/library/papers/42082463PubMed
41367907Decoding metabolic dysfunction in cancer: foundations for early detection and personalized therapeutics.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41367907PubMed
40723225Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets.Cancers (Basel)2025https://conductscience.org/library/papers/40723225PubMed
40386617The highly expressed GOLPH3 in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistance.J Gastrointest Oncol2025https://conductscience.org/library/papers/40386617PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39484162

GET https://conductscience.org/api/papers/v1/39484162/references?page=2